If you are reading this, one of three things is probably true. You have been told you need an angiogram or a stent, and separately told that the contrast dye is a risk to your kidneys because your eGFR is low. Or you have had a reaction to iodinated contrast before. Or you have already had contrast-induced kidney injury once and are not willing to risk it again.
All three lead to the same question, and it is rarely answered clearly: is there a way to do this procedure without a full load of iodine?
For a lot of vascular work below the diaphragm, there is. It is called carbon dioxide angiography, and it is not experimental — Chinese vascular units have been publishing on it, and a national multicentre study was reported at TCT 2025. But it has limits that are worth understanding before you ask any hospital about it.
First, a correction worth making early
Patients often arrive with a technique name they have read somewhere. The most common is "ultrasound-guided stenting" — the idea that the whole procedure can be done under duplex ultrasound instead of X-ray contrast.
That is not a standard technique for aortic or iliac stenting. Ultrasound can help with access and with some peripheral work, but it does not give the roadmap a stent needs.
What actually exists is a combination:
- CO₂ digital subtraction angiography (CO₂-DSA) — carbon dioxide gas used as the contrast agent.
- Intravascular ultrasound (IVUS) — measures the true lumen and vessel size from inside, with no contrast at all.
- Fusion imaging — a CT or MR roadmap overlaid on live fluoroscopy, which reduces how much contrast is needed.
- A small iodinated top-up where CO₂ is not enough.
If someone offers you "ultrasound-guided stenting", it is worth asking precisely which of the four they mean.
What decides whether this works for you
Four things, and none of them is the country.
1. Where the disease is. CO₂ works below the diaphragm — abdominal aorta, iliac arteries, renal arteries, lower limbs, dialysis access. It is not used for the thoracic aorta, the coronary arteries or intracranial vessels, because the gas rises and the margins for error are different. If your problem is above the diaphragm, this article does not apply to you.
2. Whether the centre actually runs a CO₂ protocol. Owning a machine with a CO₂ mode is not the same as using it routinely. Ask how many CO₂ cases the unit does per month, and who supervises the injections.
3. The renal artery ostium. This is the honest caveat. CO₂ does not opacify the renal ostium as well as iodine, so in published Chinese series, renal-artery stenting sometimes needed 10–15 mL of iodinated contrast even when everything else was CO₂. That is a fraction of a standard run — but it is not zero, and anyone promising a guaranteed zero-iodine procedure is overstating the technique.
4. Who reads the images. CO₂ images are lower in contrast than iodine ones and are affected by buoyancy — the gas rises, so positioning and injection technique matter. Experience is not a formality here.
What to send before anyone can answer
No vascular team can tell you whether CO₂ is feasible from a description. They need:
- Your latest creatinine and eGFR, with the date. Not "my kidneys are a bit weak".
- Any previous contrast reaction, and your thyroid status — iodine load matters there too.
- Your imaging as DICOM files, not a written report. The anatomy is the question.
- A current medication list, with generic names.
Without those four, a hospital that says "yes, we can do it" is guessing.
When this is not the right path
- The disease is above the diaphragm. Thoracic aortic work and coronary intervention are not CO₂ cases.
- You need treatment now. Ruptured aneurysm, acute limb ischaemia and similar emergencies are not the moment to arrange a specialised technique abroad.
- The hospital has no CO₂ programme. A department that has never run one will not start for a single visiting patient.
- You need a guarantee of zero iodine. Nobody can give that. The realistic aim is a large reduction, with a small top-up if the renal ostium has to be visualised.
What China has actually published
This is the part most English-language sources do not cover, so it is worth being specific.
A national multicentre prospective study, led from a Beijing aortic centre and reported at TCT 2025, enrolled patients at risk of contrast nephropathy — eGFR below 60, chronic kidney disease, iodine allergy, hyperthyroidism. It used a domestic passive automated CO₂ injector (Jetfall, Beijing AMT). All procedures were completed, there were no device-related adverse events, and blinded image-quality scoring was reported at 4.8 out of 5.
A 2025 review in the Chinese Journal of General Surgery from the same Beijing vascular group described good image quality in the abdominal aorta, renal, iliac and lower-limb arteries, and safe use in peripheral arterial disease, dialysis access and TIPS procedures. It also notes the practical infrastructure — a Siemens Artis system run in CO₂ mode, and digital variance angiography to improve image quality.
Zhejiang Provincial People's Hospital (March 2025) reported an EVAR performed with roughly 400 mL of CO₂ as the sole contrast agent in a patient with stage 3b chronic kidney disease (creatinine 176 µmol/L, eGFR 34.7). Creatinine was stable after the procedure.
Huzhou Central Hospital (2021–2025, 28 patients) published a series using CO₂ as the sole contrast: technical success in 92.9%, no significant creatinine change at 24 hours or one month, including 13 patients who already had renal impairment — and, in line with the caveat above, two renal-artery stent cases that needed 10–15 mL of iodinated contrast to finish.
The international literature points the same way. A 2026 systematic review in Diagnostics examined the diagnostic accuracy and renal safety of CO₂ angiography in lower-limb work; a 2026 review in Annals of Vascular Surgery looked at safety and effectiveness specifically for endovascular aneurysm repair.
How to ask a hospital
If you contact a centre, these four questions separate a real programme from a sales answer:
- How many CO₂ angiography cases does your department perform per month, and who supervises them?
- For my anatomy — send the images — would you plan CO₂, iodine, or a hybrid, and how much iodine do you estimate?
- Who performs the puncture and who reads the run, and what is their experience with CO₂ imaging artefact?
- If CO₂ is insufficient at any point, what is the plan, and does that change the price?
What we do, and what we do not
We are not a hospital and we do not give medical advice. What we can do is put the technical question to a vascular team in writing, in Chinese, with your imaging attached — and translate the answer back accurately, including the parts you may not want to hear.
If a centre tells us CO₂ is not appropriate for your anatomy, we will tell you that rather than find one that says yes.
The whole point of asking is to get a real answer, not a convenient one.
